Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,019 total articles
Charles M. Piluso, Chairman and CEO of Data Storage Corp (NASDAQ:DTST), executed several sales of common stock totaling $333,309. These sales were reported as satisfying tax withholding obligations. The transactions occurred while the stock was trading at a weighted average price range between $3.82 and $3.91 per share. This insider activity is vie…
D. Jonathan Merriman, a director at PodcastOne, Inc., recently acquired 7,000 shares of the company’s common stock on May 22, 2026. The purchase totaled $30,660 at a price of $4.38 per share. This transaction occurs as PodcastOne announces several strategic growth initiatives, including extending distribution agreements and launching new content ve…
Fold Holdings CEO William Brian Poppic Reeves sold a total of $19,346 worth of shares over two days in May 2026. This transaction was noted as a 'sell to cover' required for tax withholding related to restricted stock units. The sales occurred against a backdrop of challenging financial reports for the first quarter of 2026, where both earnings per…
Major institutional shareholder Luminus Energy Partners Master Fund reported substantial sales of BATTALION OIL CORP (BATL) common stock in late March 2026. These transactions, which involved the disposition of over 3 million shares, occurred against a backdrop of significant price volatility for BATL. Concurrently, the company announced several st…
Canyon Capital Advisors LLC, alongside Mitchell R. Julis and Joshua S. Friedman, reported a substantial divestment of common stock in CBL & Associates Properties Inc. (NASDAQ:CBL) on May 22, 2026. The sale accounted for 1,050,000 shares, totaling approximately $48.76 million. This transaction occurred while the company was simultaneously executing …
The CEO of Cadrenal Therapeutics, Pham Quang X, executed a stock sale valued at $6,628. This transaction occurred while the company reported key clinical progress with its drug candidate, CAD-1005, including an End-of-Phase 2 meeting with the FDA and planning for a Phase 3 trial. The stock's current valuation relative to the recent insider sale pri…
The Chief Financial Officer of WhiteHorse Finance, Inc. (WHF) recently made an insider purchase, acquiring $19,860 worth of common stock. This transaction occurred as the stock trades close to its 52-week low and following a quarter where the company’s financial results missed analyst expectations.
The Chief Executive Officer of WhiteHorse Finance, Inc., Stuart D. Aronson, recently increased his personal holdings by acquiring 32,000 shares of the company's common stock over two days in May 2026. This insider buying occurred against a backdrop of recent financial results for Q1 2026 that underperformed analyst expectations. The report details …
A collective group of entities associated with Partners Group sold a substantial amount of common stock in Life Time Group Holdings, Inc. (NASDAQ: LTH) on May 21, 2026. This transaction involved the disposition of 449,960 shares at $32.51 per share, generating proceeds totaling approximately $14.6 million. The sale occurred while LTH stock was trad…
The recent activities of a director at Life Time Group Holdings, Inc. (NYSE: LTH) indicate a substantial sale of common stock. This reported transaction occurs against a backdrop of strong market performance for the company's shares and positive commentary from major financial institutions regarding its future growth. Furthermore, Life Time recentl…
Entities connected to the private equity firm Leonard Green & Partners reported substantial sales of Life Time Group Holdings, Inc. (LTH) common stock totaling nearly $98 million on May 21, 2026. These transactions occurred despite positive developments for LTH, including the launch of a new nutrition service and multiple analyst upgrades from …
John Kristofer Galashan, a director at Life Time Group Holdings, Inc. (NASDAQ: LTH), recently sold shares totaling $97.7 million. This insider selling news is contextualized by recent positive quarterly results, increased price targets from major investment banks, and the company's ongoing strategic initiatives.
FLEX LTD.'s director, Erin McSweeney, recently sold a block of company shares in an SEC filing. This transaction occurs against a backdrop of positive corporate developments for FLEX Ltd., including strong quarterly earnings and plans to spin off its Cloud & Power infrastructure segment. Concurrently, Nextpower announced a significant acquisition o…
Flex Ltd.'s Chief Executive Officer, Revathi Advaithi, recently sold a substantial block of company stock through a pre-arranged trading plan. This activity occurs as the firm's shares trade near their 52-week peak, following significant gains and positive operational updates, including strong quarterly earnings and plans to spin off its Cloud & Po…
Michael George Rosenbaum, CEO of Guidewire Software, Inc., recently executed a sale of company stock valued at $166,212. This disposal was managed through a pre-arranged 10b5-1 trading plan on May 26, 2026. The transaction occurred while the stock had seen a notable decline over the preceding six months. Despite this recent price action and executi…
The Mark & Robyn Jones Descendants Trust 2014 sold 45,588 shares of Goosehead Insurance's Class A Common Stock totaling $1.83 million on May 26, 2026. This transaction took place after the trust converted an equal number of Class B shares to Class A shares. Separately, the company reported robust first-quarter 2026 results, with earnings per share …
Gaurav Shah, CEO of Rocket Pharmaceuticals (NASDAQ:RCKT), recently reported selling a significant block of common stock following the exercise of an option. This transaction occurred alongside other stock movements that highlight insider activity. Separately, the company has secured major strategic wins, including the sale of its Rare Pediatric Dis…
Jeffrey Jones, the Chief Financial Officer at COHU INC, sold a total of 13,000 shares amounting to $608,920 on May 22, 2026. This transaction occurred as Cohu's stock was trading near its 52-week high and following significant positive momentum. Despite the insider sale, the company recently reported first-quarter revenue of $125.1 million, surpass…
Nicole Sweeny, Chief Commercial Officer of KalVista Pharmaceuticals (NASDAQ:KALV), recently reported a sale of company stock. This transaction occurred after she had acquired shares via the settlement of restricted stock units (RSUs). The news also highlights that KalVista is in advanced merger talks with Chiesi Group for $27.00 per share, a deal e…
Chief Development Officer Christopher Yea recently sold shares of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) as part of a tax withholding process related to vested restricted stock units (RSUs). This transaction occurred while the company was also in the news for entering a merger agreement with Chiesi Group, valuing KALV at $1.9 billion.
Cohu's leadership sold a notable amount of stock recently, occurring while the company's shares have seen substantial gains. This transaction coincides with Q1 2026 financial results that showed mixed performance: exceeding revenue forecasts but failing to meet earnings per share expectations. Despite this initial stumble, Cohu provided an optimist…
Arista Networks director Kelly Battles executed a sale of company stock totaling $61,797 on May 21, 2026. This transaction occurred as Arista's share price continues to rise, reaching $158.01 and showing substantial growth over the past year. Despite the insider activity, recent financial reports indicate strong performance for Arista Networks, inc…
Paul K. Audhya, Chief Medical Officer at KalVista Pharmaceuticals, Inc., recently sold a block of common stock shares. This transaction was reportedly to cover tax obligations related to the settlement of restricted stock units (RSUs). The report details this sale in the context of the company's pending merger agreement with Chiesi Group, which val…
The Chief Financial Officer of KalVista Pharmaceuticals, Inc., Brian Piekos, recently completed a sale of company stock. This disposition was related to covering tax obligations arising from the vesting and settlement of restricted stock units (RSUs). These transactions occurred against a backdrop of significant corporate developments for KalVista,…
Director Kang Sun of Amprius Technologies, Inc. (NASDAQ:AMPX) executed a sale of common stock shares on May 21, 2026. The transaction was part of mandated 'sell-to-cover' arrangements used to fulfill tax withholding obligations from vested restricted stock units. In other corporate developments, the company reported its Q1 2026 earnings, noting a n…
